Antinociceptive effect of novel trihalomethyl-substituted pyrazoline methyl esters in formalin and hot-plate tests in mice

Beirith, 1998, Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action, Eur. J. Pharmacol., 345, 233, 10.1016/S0014-2999(98)00026-0 Bekhit, 2004, Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory–antimicrobial agents, Bioorg. Med. Chem., 12, 1935, 10.1016/j.bmc.2004.01.037 Camu, 2002, Pharmacology of systemic analgesics, Best Pract. Res. Clin. Anaesthesiol., 16, 475, 10.1053/bean.2002.0262 Carlsson, 1986, Activation of inhibition from the periaqueductal grey matter mediates central analgesic effect of metamizol (dipyrone), Pain, 27, 373, 10.1016/0304-3959(86)90161-2 Cheng, 1986, Pyrazole derivatives. Synthesis and antineoplastic activity of 3-(2 chloroethyl)-3,4-dihydro-4-oxopyrazolo{5,1-d}-1,2,3,5-tetrazine-8 carboxamide and related compounds, J. Med. Chem., 29, 1544, 10.1021/jm00158a041 Collett, 1998, Opioid tolerance: the clinical perspective, Br. J. Anaesth., 81, 58, 10.1093/bja/81.1.58 Dailly, 2006, Specificity and efficacy of noradrenaline, serotonin depletion in discrete brain areas of Swiss mice by neurotoxins, J. Neurosci. Methods, 150, 111, 10.1016/j.jneumeth.2005.06.008 De Souza, 2001, 3-Methyl 5-hydroxy-5-trichloromethyl -1H-1-pyrazolcarboxyamide (MPCA) induces antinociception, Pharmacol. Biochem. Behav., 68, 525, 10.1016/S0091-3057(01)00453-1 Edwards, 2001, Single-dose dipyrone for acute postoperative pain, Cochrane Database Syst. Rev., 3, CD003227 Ferreira, 2000, Antinociceptive properties of the methanolic extract and two triterpenes isolated from Epidendrum mosenii stems (Orchidaceae), Life Sci., 66, 791, 10.1016/S0024-3205(99)00652-9 Ferreira, 2002, The use of B1 and B2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal level, Neuropharmacology, 43, 1188, 10.1016/S0028-3908(02)00311-8 Godoy, 2004, α2-Adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazoles, but not of dipyrone, Eur. J. Pharmacol., 496, 93, 10.1016/j.ejphar.2004.05.045 Gürsoy, 2000, Synthesis and preliminary evaluation of new 5-pyrazolinone derivatives as analgesic agents, Eur. J. Med. Chem., 35, 359, 10.1016/S0223-5234(00)00117-3 Hayes, 1983, Determination of receptors that mediate opiate side effects in the mouse, Br. J. Pharmacol., 79, 731, 10.1111/j.1476-5381.1983.tb10011.x Hernández-Delgadillo, 2002, Metamizol potentiates morphine antinociception but not constipation after chronic treatment, Eur. J. Pharmacol., 441, 177, 10.1016/S0014-2999(02)01344-4 Hernández-Delgadillo, 2003, Morphine and dipyrone co-administration delays tolerance development and potentiates antinociception, Eur. J. Pharmacol., 469, 71, 10.1016/S0014-2999(03)01727-8 Hunskaar, 1987, The formalin test in mice: dissociation between inflammatory and non-inflammatory pain, Pain, 30, 103, 10.1016/0304-3959(87)90088-1 Jage, 2005, Opioid tolerance and dependence. Do they matter?, Eur. J. Pain, 9, 157, 10.1016/j.ejpain.2004.11.009 Karthikeyan, 2007, Synthesis and antimicrobial studies on novel chloro-fluorine containing hydroxyl pyrazolines, Eur. J. Med. Chem., 42, 30, 10.1016/j.ejmech.2006.07.011 Kieffer, 2002, Opioid tolerance-in search of the holy grail, Cell, 108, 587, 10.1016/S0092-8674(02)00666-9 Martins, 2006, Microwave-assisted synthesis of novel 5-trichloromethyl-4,5-dihydro-1H-1-pyrazole methyl esters under solvent free conditions, J. Braz. Chem. Soc., 17, 408, 10.1590/S0103-50532006000200027 Matheus, 1991, Antinociceptive property of new 4-acyl-arylhydrazone pyrazole compounds, Braz. J. Med. Biol. Res., 24, 1219 McQuay, 2005, NSAIDS and coxibs: clinical use, 471 Mercadante, 1999, Problems of long-term spinal opioid treatment in advanced cancer patients, Pain, 79, 1, 10.1016/S0304-3959(98)00118-3 Miranda, 2003, Effect of the inhibition of serotonin biosynthesis on the antinociception induced by nonsteroidal anti-inflammatory drugs, Brain Res. Bull., 61, 417, 10.1016/S0361-9230(03)00144-8 Ochi, 2000, The antinociceptive effect of FR 140423 in mice: involvement of spinal α2-adrenoceptors, Eur. J. Pharmacol., 400, 199, 10.1016/S0014-2999(00)00402-7 Ochi, 2000, The antinociceptive effect induced by FR 140423 is mediated through spinal 5-HT2A and 5-HT3 receptors, Eur. J. Pharmacol., 409, 167, 10.1016/S0014-2999(00)00832-3 Ochi, 1999, Anti-inflammatory and analgesics effects of a pyrazole derivative FR140423, Eur. J. Pharmacol., 365, 259, 10.1016/S0014-2999(98)00868-1 Ochi, 1999, Antinociceptive properties of FR140423 mediated through spinal δ-, but not µ- and κ-, opioid receptors, Eur. J. Pharmacol., 380, 73, 10.1016/S0014-2999(99)00522-1 Ochi, 2000, The spinal antinociceptive effect of FR140423 is mediated through kyotorphin receptors, Life Sci., 66, 2239, 10.1016/S0024-3205(00)00552-X Ochi, 2002, FR 143166 attenuates spinal pain transmission through activation of the serotonergic system, Eur. J. Pharmacol., 452, 319, 10.1016/S0014-2999(02)02334-8 Otuki, 2005, Antinociceptive properties of mixture of alpha-amyrin and beta-amyrin triterpenes: evidence for participation of protein kinase C and protein kinase A pathways, J. Pharmacol. Exp. Ther., 313, 310, 10.1124/jpet.104.071779 Parck, 2001, Metabolism of fluorine-containing drugs, Annu. Rev. Pharmacol. Toxicol., 41, 443, 10.1146/annurev.pharmtox.41.1.443 Pasternak, 2001, Incomplete cross tolerance and multiple mu opioid peptide receptors, Trends Pharmacol. Sci., 22, 67, 10.1016/S0165-6147(00)01616-3 Popova, 1989, Lack of direct interaction of metamyzole with the brain opiate receptors of rats, Acta Physiol. Pharmacol. Bulg., 15, 55 Puig, 1997, Reversal of tolerance to the antitransit effects of morphine during acute intestinal inflammation in mice, Br. J. Pharmacol., 122, 1216, 10.1038/sj.bjp.0701472 Santos, 1999, Antinociceptive properties of the new alkaloid, cis-8, 10-di-N-propyllobelidiol hydrochloride dihydrate isolated from Siphocampylus verticillatus: evidence for the mechanism of action, J. Pharmacol. Exp. Ther., 289, 417 Shibata, 1989, Modified formalin test: characteristic biphasic pain response, Pain, 38, 347, 10.1016/0304-3959(89)90222-4 Siegfried, 1987, Exposure to novetly induces naltrexone-reversible analgesia in rats, Behav. Neurosci., 101, 436, 10.1037/0735-7044.101.3.436 Souza, 2002, Hypotermic and antipyretic effects of 3-methyl and 3-phenyl-5-hydroxy-5-trichloromethyl-4,5-dihydro-1H-pyrazole-1-carboxyamides, Eur. J. Pharmacol., 451, 141, 10.1016/S0014-2999(02)02225-2 Tabarelli, 2004, Antinociceptive effect of novel pyrazolines in mice, Braz. J. Med. Biol. Res., 37, 1531, 10.1590/S0100-879X2004001000013 Tjolsen, 1992, The formalin test: an evaluation of the method, Pain, 51, 5, 10.1016/0304-3959(92)90003-T Vlaskovska, 1989, Importance of endogenous opioids and prostaglandins in the action of analgin (metamizole) and verapamil, Farmakol. Toksikol., 52, 25 Whittle, 2003, Gastrointestinal effects of nonsteroidal anti-inflammatory drugs, Fundam. Clin. Pharmacol., 17, 301, 10.1046/j.1472-8206.2003.00135.x Zimmermann, 1983, Ethical guidelines for investigations of experimental pain in conscious animals, Pain, 16, 109, 10.1016/0304-3959(83)90201-4